Summery_2018_04

According to the Digest`s Editorial office opinion, the main events of the April 2018 in Russian pharmaceutical industry are:

- Good distribution practice (GDP) regulations for medicinal products came into force in the Eurasian Economic Union (EAEU);

- The Ministry of Telecom and Mass Communications of the Russian Federation did not support the idea of banning TV advertising of medicinal products;

- Anti-sanctions proposed by the State Duma could put the lives of thousands of Russian citizens at risk;

- The Federal Antimonopoly Service of Russia (FAS) forced AstraZeneca to lower the prices of five medicines;

- personnel appointments in the pharmaceutical industry.

These, as well as all other industry month news, are in the April 2018 issue of the Digest.

Best regards,

Andrei Egorov, Editor-in-Chief

01.05.2018.